PANTHERx® Rare Introduces New Capabilities to Support Cell and Gene Therapies

PANTHERx® Rare Introduces New Capabilities to Support Cell and Gene Therapies

PITTSBURGH, April 2, 2025 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce the launch of RxARECONCIERGE™, a new patient support model to improve access, logistics,…

In Leipzig, researchers talk about progress in modern therapies with genetically modified viruses. Although these approaches are expensive, they can now cure life-long diseases with a unique gift.

AscellaHealth Launches Specialty & Rare Pipeline Digest to Guide Pharmaceutical Stakeholders

BERWYN, PA — AscellaHealth has introduced its latest Specialty & Rare Pipeline Digest™, a quarterly publication designed to provide stakeholders with comprehensive insights into current and upcoming specialty and rare disease drug developments. The digital resource focuses on new drug launches, regulatory approvals, and advancements in biosimilars, as well as cell and gene therapies (CGTs). The initiative supports stakeholders navigating the dyn…

Cellares to open five facilities to support cell therapy tech

These plants will incorporate Cellares’ Cell Shuttle platform, which has received AMT designation from the US FDA, along with its Cell Q technology.